Insider Transactions in Q1 2024 at Taysha Gene Therapies, Inc. (TSHA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2024
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-0.15%
|
$1,288
$1.51 P/Share
|
|
Jan 02
2024
|
Sean P. Nolan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,184,688
+49.98%
|
-
|
|
Jan 02
2024
|
Sukumar Nagendran President and Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
863,617
+49.03%
|
-
|
|
Jan 02
2024
|
Kamran Alam CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
590,413
+41.21%
|
-
|